Antonio Raffone Selected Research

Endometrial Hyperplasia

9/2022	Dusp6 immunohistochemistry is associated with the response of atypical endometrial hyperplasia and early endometrial cancer to conservative treatment.
1/2021	Predictive Accuracy of Progesterone Receptor B in Young Women with Atypical Endometrial Hyperplasia and Early Endometrial Cancer Treated with Hysteroscopic Resection plus LNG-IUD Insertion.
1/2021	Clinical Predictive Factors of Response to Treatment in Patients Undergoing Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer.
1/2021	Mismatch repair-deficiency specifically predicts recurrence of atypical endometrial hyperplasia and early endometrial carcinoma after conservative treatment: A multi-center study.
1/2020	Immunophenotype of Atypical Polypoid Adenomyoma of the Uterus: Diagnostic Value and Insight on Pathogenesis.
1/2020	Predictive accuracy of hormone receptors in conservatively treated endometrial hyperplasia and early endometrioid carcinoma.
11/2019	Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy.
11/2019	Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment.
5/2019	Hysteroscopic Endometrial Focal Resection followed by Levonorgestrel Intrauterine Device Insertion as a Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Cancer: A Retrospective Study.
4/2019	PTEN immunohistochemistry in endometrial hyperplasia: which are the optimal criteria for the diagnosis of precancer?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Raffone Research Topics

Disease

18	Endometrial Neoplasms (Endometrial Cancer) 09/2022 - 12/2018
15	Neoplasms (Cancer) 12/2022 - 10/2018
13	Endometrial Hyperplasia 09/2022 - 12/2018
6	Endometriosis 11/2022 - 05/2020
6	Carcinoma (Carcinomatosis) 08/2022 - 01/2020
6	Endometrioid Carcinoma 09/2021 - 11/2019
4	Turcot syndrome 12/2021 - 01/2020
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2021 - 01/2020
3	Wounds and Injuries (Trauma) 02/2021 - 09/2020
2	Metaplasia 08/2022 - 01/2020
2	Leiomyosarcoma 03/2022 - 05/2020
2	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2020
2	Placenta Accreta 02/2021 - 01/2021
2	Carcinogenesis 01/2021 - 09/2019
2	Hemorrhage 01/2021 - 05/2020
2	Postpartum Hemorrhage 10/2020 - 03/2020
2	Leiomyoma (Uterine Fibroids) 05/2020 - 02/2020
2	Premature Birth (Birth, Premature) 04/2019 - 10/2018
2	Rupture 04/2019 - 01/2019
1	Adenomyoma 10/2022
1	Hydronephrosis 07/2022
1	Adenomyosis 05/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2022
1	Rubella (German Measles) 02/2022
1	Congenital Abnormalities (Deformity) 02/2022
1	Toxoplasmosis 02/2022
1	Ovarian Torsion 01/2022
1	Infections 01/2022
1	Craniopharyngioma (Craniopharyngiomas) 09/2021
1	Odontogenic Tumors (Dental Tissue Neoplasm) 09/2021
1	Pain (Aches) 01/2021
1	Cicatrix (Scar) 01/2021
1	Urinary Incontinence 01/2021
1	Breast Neoplasms (Breast Cancer) 10/2020
1	Lymphatic Metastasis 10/2020
1	Vulvar Neoplasms (Vulvar Cancer) 09/2020
1	Microsatellite Instability 07/2020
1	Myoma 05/2020
1	Accidental Injuries 05/2020
1	Intraoperative Complications 05/2020
1	Postoperative Pain 05/2020
1	Cysts 01/2020
1	Ovarian Cysts (Ovarian Cyst) 01/2020
1	Ovarian Epithelial Carcinoma 01/2020
1	Ascites 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Diabetes Mellitus 11/2019

Drug/Important Bio-Agent (IBA)

8	CateninsIBA 01/2022 - 01/2019
7	Proteins (Proteins, Gene)FDA Link 03/2022 - 03/2019
5	Progestins (Progestagens)IBA 11/2019 - 12/2018
3	Estrogen ReceptorsIBA 01/2021 - 01/2019
2	VaccinesIBA 02/2022 - 01/2022
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2021
2	Calmodulin-Binding Proteins (Caldesmon)IBA 11/2020 - 01/2020
2	Tranexamic Acid (AMCA)FDA Link 10/2020 - 03/2020
2	Hormones (Hormone)IBA 01/2020 - 01/2020
2	Progesterone FDA LinkGeneric 04/2019 - 01/2019
1	Troleandomycin (TAO)FDA Link 12/2022
1	lipoarabinomannan (LAM)IBA 11/2022
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 09/2022
1	Dual Specificity Phosphatase 6IBA 09/2022
1	alpha-methylacyl-CoA racemaseIBA 08/2022
1	Carrier Proteins (Binding Protein)IBA 04/2022
1	C-Reactive ProteinIBA 01/2022
1	AerosolsIBA 01/2022
1	VimentinIBA 12/2021
1	Keratins (Keratin)IBA 09/2021
1	Exonucleases (3' 5' Exonuclease)IBA 01/2021
1	Differentiation AntigensIBA 01/2021
1	Claudin-4IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	progesterone receptor BIBA 01/2021
1	Sucrose (Saccharose)IBA 01/2021
1	Nucleic AcidsIBA 10/2020
1	InterleukinsIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 09/2019
1	Levonorgestrel (Plan B)FDA LinkGeneric 05/2019

Therapy/Procedure

9	Hysterectomy 10/2022 - 10/2018
9	Conservative Treatment 10/2022 - 12/2018
5	Therapeutics 05/2021 - 12/2018
3	Uterine Myomectomy 05/2020 - 10/2018
2	Stents 07/2022 - 02/2021
2	Drug Therapy (Chemotherapy) 03/2022 - 01/2022
2	Neoadjuvant Therapy 01/2022 - 09/2021
2	Cesarean Section (Caesarean Section) 01/2021 - 01/2021
2	Morcellation 05/2020 - 10/2018
1	Minimally Invasive Surgical Procedures 07/2022
1	Cystectomy 01/2022
1	Lasers (Laser) 01/2021
1	Hysteroscopes 01/2021
1	Dilatation and Curettage 12/2020
1	Lymph Node Excision (Lymph Node Dissection) 09/2020
1	Negative-Pressure Wound Therapy 09/2020
1	Postoperative Care 09/2020
1	Vulvectomy 09/2020
1	Laparotomy 05/2020
1	Length of Stay 05/2020
1	Operative Time 05/2020
1	Intrauterine Devices (Intrauterine Device) 05/2019